Results 301 to 309 of about 287,634 (309)

Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis

New England Journal of Medicine, 2017
Xavier Montalban, Stephen L Hauser, Ludwig Kappos   +2 more
exaly  

Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis

New England Journal of Medicine, 2012
Robert J Fox, Michael Hutchinson, Vissia Viglietta   +2 more
exaly  

Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis

New England Journal of Medicine, 2012
Ludwig Kappos, Douglas L Arnold, Gavin Giovannoni   +2 more
exaly  

FDA reversal sends mixed message to multiple sclerosis community

Nature Reviews Drug Discovery, 2014
exaly  

The multiple sclerosis market

Nature Reviews Drug Discovery, 2017
exaly  

Systemic Sclerosis

2018
Jonathan Paek, Shobana Chandrasekhar
openaire   +1 more source

Systemic Sclerosis

1988
John A. Cosh, John V. Lever
openaire   +1 more source

SCLERODERMA 710.1 (Systemic Sclerosis, Progressive Systemic Sclerosis)

2008
openaire   +1 more source

[Systemic sclerosis].

Praxis, 1997
openaire   +1 more source